Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.38
+0.07
(+0.26%)
After-Hours: 07:32
Ionis Pharmaceuticals Shareholders Equity (Quarterly) : 393.64M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 393.64M |
| June 30, 2026 | 439.74M |
| March 31, 2026 | 491.41M |
| December 31, 2025 | 489.09M |
| September 30, 2025 | 617.97M |
| June 30, 2025 | 631.72M |
| March 31, 2025 | 475.73M |
| December 31, 2024 | 588.35M |
| September 30, 2024 | 662.47M |
| June 30, 2024 | 263.70M |
| March 31, 2024 | 296.52M |
| December 31, 2023 | 386.69M |
| September 30, 2023 | 315.46M |
| June 30, 2023 | 428.30M |
| March 31, 2023 | 486.57M |
| December 31, 2022 | 572.89M |
| September 30, 2022 | 594.36M |
| June 30, 2022 | 624.73M |
| March 31, 2022 | 709.57M |
| December 31, 2021 | 771.74M |
| September 30, 2021 | 530.54M |
| June 30, 2021 | 582.67M |
| March 31, 2021 | 680.56M |
| December 31, 2020 | 743.28M |
| September 30, 2020 | 1.383B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.377B |
| March 31, 2020 | 1.360B |
| December 31, 2019 | 1.471B |
| September 30, 2019 | 1.336B |
| June 30, 2019 | 1.269B |
| March 31, 2019 | 1.208B |
| December 31, 2018 | 1.048B |
| September 30, 2018 | 710.55M |
| June 30, 2018 | 696.26M |
| March 31, 2018 | 301.39M |
| December 31, 2017 | 281.01M |
| September 30, 2017 | 307.97M |
| June 30, 2017 | 215.57M |
| March 31, 2017 | 201.81M |
| December 31, 2016 | 99.56M |
| September 30, 2016 | 139.64M |
| June 30, 2016 | 111.21M |
| March 31, 2016 | 158.16M |
| December 31, 2015 | 200.79M |
| September 30, 2015 | 245.41M |
| June 30, 2015 | 300.32M |
| March 31, 2015 | 275.85M |
| December 31, 2014 | 257.78M |
| September 30, 2014 | 344.77M |
| June 30, 2014 | 366.86M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| BridgeBio Pharma, Inc. | -1.662B |
| Biogen, Inc. | 18.92B |
| Ultragenyx Pharmaceutical, Inc. | -376.00M |
| Krystal Biotech, Inc. | 1.436B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.913B |
| Total Liabilities (Quarterly) | 2.519B |
| Debt to Equity Ratio | 5.520 |
| Current Ratio | 5.425 |
| Net Debt Paydown Yield | -0.53% |